Olema Pharmaceuticals Inc.
OLMA | NASDAQ
$9.64
+$0.01 (+0.10%)
Sep 22, 2026, 1:41 PM ET · Market open
Fiscal Quarter Period Ending | Q2 2026 Jun 29, 2026 | Q1 2026 Mar 30, 2026 | Q4 2025 Dec 30, 2025 | Q3 2025 Sep 29, 2025 | Q2 2025 Jun 29, 2025 | Q1 2025 Mar 30, 2025 | Q4 2024 Dec 30, 2024 | Q3 2024 Sep 29, 2024 | Q2 2024 Jun 29, 2024 | Q1 2024 Mar 30, 2024 | Q4 2023 Dec 30, 2023 | Q3 2023 Sep 29, 2023 | Q2 2023 Jun 29, 2023 | Q1 2023 Mar 30, 2023 | Q4 2022 Dec 30, 2022 | Q3 2022 Sep 29, 2022 | Q2 2022 Jun 29, 2022 | Q1 2022 Mar 30, 2022 | Q4 2021 Dec 30, 2021 | Q3 2021 Sep 29, 2021 | Q2 2021 Jun 29, 2021 | Q1 2021 Mar 30, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost of Revenue | n/a | 119K | 187K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit | n/a | -119K | -187K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Income | -67.18M | -57.99M | -50.08M | -45.88M | -47.86M | -34.87M | -36.77M | -37.62M | -33.53M | -34.34M | -30.42M | -23.34M | -21.6M | -29.6M | -27.22M | -23.22M | -33.29M | -23.25M | -21.76M | -17.76M | -16.52M | -15.45M |
Interest Income | 4.51M | 4.78M | 4.01M | 3.65M | 4.04M | 4.52M | 3.29M | 2.93M | 3.11M | 3.35M | 3.55M | 1.92M | 1.55M | 1.31M | 973K | 622K | 415K | 218K | 109K | 105K | 117K | 111K |
Pretax Income | -63.2M | -53.09M | -46.06M | -42.22M | -43.78M | -30.39M | -33.57M | -34.56M | -30.38M | -30.97M | -26.77M | -21.5M | -20.1M | -28.29M | -26.18M | -22.72M | -32.86M | -23.03M | -21.64M | -17.71M | -16.41M | -15.34M |
Net Income | -63.2M | -53.09M | -46.06M | -42.22M | -43.78M | -30.39M | -33.57M | -34.56M | -30.38M | -30.97M | -26.77M | -21.5M | -20.1M | -28.29M | -26.18M | -22.72M | -32.86M | -23.03M | -21.64M | -17.71M | -16.41M | -15.34M |
Selling & General & Admin | 9.39M | 8.64M | 6.86M | 5.93M | 3.96M | 4.25M | 4.47M | 4.4M | 4.42M | 4.46M | 4.54M | 3.89M | 3.61M | 6.78M | 5.64M | 5.6M | 6.24M | 7.25M | 5.78M | 5.24M | 4.61M | 4.76M |
Research & Development | 57.79M | 49.23M | 43.22M | 39.95M | 43.9M | 30.62M | 32.3M | 33.23M | 29.11M | 29.88M | 25.87M | 19.45M | 17.99M | 22.83M | 21.58M | 17.63M | 27.05M | 16.01M | 15.98M | 12.52M | 11.91M | 10.69M |
Other Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Expenses | 67.18M | 57.87M | 49.9M | 45.88M | 47.86M | 34.87M | 36.77M | 37.62M | 33.53M | 34.34M | 30.42M | 23.34M | 21.6M | 29.6M | 27.22M | 23.22M | 33.29M | 23.25M | 21.76M | 17.76M | 16.52M | 15.45M |
Interest Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Selling & Marketing Expenses | n/a | -119K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 67.18M | 57.99M | 50.08M | 45.88M | 47.86M | 34.87M | 36.77M | 37.62M | 33.53M | 34.34M | 30.42M | 23.34M | 21.6M | 29.6M | 27.22M | 23.22M | 33.29M | 23.25M | 21.76M | 17.76M | 16.52M | 15.45M |
Income Tax Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Shares Outstanding (Basic) | 104.45M | 102.8M | 91.32M | 85.73M | 85.5M | 85.43M | 58.74M | 57.26M | 56.28M | 55.57M | 54.78M | 44.98M | 40.72M | 40.35M | 40.19M | 40.04M | 39.92M | 39.83M | 39.74M | 39.61M | 39.42M | 39.33M |
Shares Outstanding (Diluted) | 104.45M | 102.8M | 91.32M | 85.73M | 85.5M | 85.43M | 58.74M | 57.26M | 56.28M | 55.57M | 54.78M | 44.98M | 40.72M | 40.35M | 40.19M | 40.04M | 39.92M | 39.83M | 39.74M | 39.61M | 39.42M | 39.33M |
EPS (Basic) | -0.61 | -0.52 | -0.50 | -0.49 | -0.51 | -0.36 | -0.57 | -0.60 | -0.54 | -0.56 | -0.49 | -0.48 | -0.49 | -0.67 | -0.63 | -0.55 | -0.82 | -0.57 | -0.54 | -0.45 | -0.42 | -0.39 |
EPS (Diluted) | -0.61 | -0.52 | -0.51 | -0.49 | -0.51 | -0.36 | -0.57 | -0.60 | -0.54 | -0.56 | -0.49 | -0.48 | -0.49 | -0.67 | -0.63 | -0.55 | -0.82 | -0.57 | -0.54 | -0.45 | -0.42 | -0.39 |
EBITDA | -62.98M | -52.97M | -45.87M | -42.17M | -43.65M | -30.26M | -33.45M | -34.46M | -30.29M | -30.88M | -26.68M | -21.41M | -20M | -28.19M | -26.08M | -22.63M | -32.77M | -22.95M | -21.57M | -17.66M | -16.38M | -15.44M |
EBIT | -63.2M | -53.09M | -46.06M | -42.22M | -43.78M | -30.39M | -33.57M | -34.56M | -30.38M | -30.97M | -26.77M | -21.5M | -20.1M | -28.29M | -26.18M | -22.72M | -32.86M | -23.03M | -21.64M | -17.71M | -16.41M | -15.45M |
Depreciation & Amortization | 221K | 119K | 187K | 43K | 132K | 128K | 116K | 95K | 94K | 88K | 88K | 90K | 99K | 100K | 97K | 91K | 85K | 84K | 73K | 50K | 31K | 9K |
Add to Watchlist
Select watchlists to add or remove OLMA